Provided by Tiger Trade Technology Pte. Ltd.

X4 Pharmaceuticals Inc

4.04
-0.0300-0.74%
Post-market: 4.040.00000.00%19:30 EDT
Volume:360.96K
Turnover:1.46M
Market Cap:400.55M
PE:-3.26
High:4.17
Open:4.10
Low:4.02
Close:4.07
52wk High:4.83
52wk Low:2.80
Shares:99.15M
Float Shares:62.35M
Volume Ratio:0.86
T/O Rate:0.58%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.2404
EPS(LYR):-1.8726
ROE:-113.08%
ROA:-28.15%
PB:2.58
PE(LYR):-2.16

Loading ...

X4 Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Reuters
·
Yesterday

X4 Pharmaceuticals Grants New Hires Options for 50,000 Shares at $4.04 Each

Reuters
·
Yesterday

X4 Pharmaceuticals Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 07

X4 Pharmaceuticals Q2 EPS $(0.13) Beats $(0.18) Estimate, Sales $8.806M Beat $2.420M Estimate

Benzinga Earnings
·
Aug 07

X4 Pharmaceuticals Q2 Operating Expenses USD 25.197 Million

Reuters
·
Aug 07

X4 Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Corporate Update

THOMSON REUTERS
·
Aug 07

X4 Pharmaceuticals Inc Expected to Post a Loss of 18 Cents a Share - Earnings Preview

Reuters
·
Aug 05

X4 Pharmaceuticals Issues Inducement Stock Options for 12,000 Shares at $3.98 Each

Reuters
·
Aug 04

X4 Pharmaceuticals Inc : Wells Fargo Initiates Coverage with Overweight Rating; Price Target $11

THOMSON REUTERS
·
Jul 10

X4 Pharmaceuticals Issues Inducement Stock Options for 750,000 Shares at $4.03 Each

Reuters
·
Jul 08

X4 Pharmaceuticals Director Kelly Gold Files Initial Beneficial Ownership Statement

Reuters
·
Jul 02

Press Release: X4 Pharmaceuticals Appoints Kelly Gold, Experienced Chief Financial Officer, to Its Board of Directors

Dow Jones
·
Jul 01

X4 Pharmaceuticals Initiated at Outperform by Leerink Partners

Dow Jones
·
Jun 02

X4 Pharmaceuticals initiated with an Outperform at Leerink

TIPRANKS
·
Jun 02

X4 Pharmaceuticals Inc : Leerink Partners Initiates Coverage With Outperform Rating; Price Target $12

THOMSON REUTERS
·
Jun 02

U.S. RESEARCH ROUNDUP-Edgewise Therapeutics, IBM, Rubrik

Reuters
·
Jun 02

BRIEF-X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule

Reuters
·
Jun 02

X4 Pharmaceuticals grants 160,000 inducement stock options priced at $4.31 per share

Reuters
·
Jun 02

X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
Jun 02

X4 Pharma to present at Jefferies Global Healthcare Conference

Reuters
·
May 27